| Dr Sudha Rani Kailas, MD, PHD | |
|
2504 Camino Entrada, Santa Fe, NM 87507-4851 | |
| (505) 471-5006 | |
| Not Available |
| Full Name | Dr Sudha Rani Kailas |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 2504 Camino Entrada, Santa Fe, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295945897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | MD2012-0061 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sudha Rani Kailas, MD, PHD 2504 Camino Entrada, Santa Fe, NM 87507-4851 Ph: (505) 471-5006 | Dr Sudha Rani Kailas, MD, PHD 2504 Camino Entrada, Santa Fe, NM 87507-4851 Ph: (505) 471-5006 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Despite repeated health warnings about the dangers of tanning from sunlight and artificial light sources, there are still those whose mantra "bronzed is beautiful" remains unshaken.
The existing prognostic scores for early-risk stroke prediction after transient ischaemic attack (TIA have been validated and refined to develop a unified score that is more predictive than previous methods, according to an Article published in this week's issue of The Lancet.
Nearly half of men initially managed with active surveillance for "low-risk" prostate cancer transition to definitive treatment – such as surgery or radiation therapy – within a few years after diagnosis.
› Verified 7 days ago
Larry Dwight Holden, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 E Golden Eagle Rd, Santa Fe, NM 87506 Phone: 505-988-7476 Fax: 505-986-6453 | |
Dr. Douglas A Puryear, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4 Camino De Vecinos, Santa Fe, NM 87507 Phone: 505-982-9337 | |
Mr. Lawrence W. Lazarus, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 2826 Plaza Verde, Santa Fe, NM 87507 Phone: 505-820-2302 Fax: 505-982-4777 | |
Julia Anne Weinstein, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 150 Washington Ave Ste 201, Santa Fe, NM 87501 Phone: 971-241-8963 Fax: 505-395-4501 | |
Edward Joseph Neidhardt, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 103 S Saint Francis Dr, Suite C, Santa Fe, NM 87501 Phone: 505-988-5667 Fax: 505-820-1632 | |
Ron Tintner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 61 Thundercloud Rd, Santa Fe, NM 87506 Phone: 615-345-5400 Fax: 888-468-6603 | |
Dr. Karl Arthur Ray, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 455 Saint Michaels Dr, St. Vincent Regional Medical Center, Santa Fe, NM 87505 Phone: 505-820-5985 Fax: 505-989-6489 |